Yu Waye Chu
Chief Tech/Sci/R&D Officer en CYTOMX THERAPEUTICS, INC. .
Fortuna: 1 M $ al 31/03/2024
Perfil
Yu Waye Chu ocupa el cargo de Vicepresidente Senior de Desarrollo Clínico en Fate Therapeutics, Inc. Se licenció en la Universidad de Princeton y se doctoró en la Facultad de Medicina y Odontología de la Universidad de Rochester.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
FATE THERAPEUTICS, INC.
0.14% | 18/04/2023 | 140 676 ( 0.14% ) | 1 M $ | 31/03/2024 |
| 18/01/2024 | 26 250 ( 0.04% ) | 57 225 $ | 31/03/2024 |
Cargos activos de Yu Waye Chu
| Empresas | Cargo | Inicio |
|---|---|---|
| CYTOMX THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 17/07/2023 |
Antiguos cargos conocidos de Yu Waye Chu.
| Empresas | Cargo | Fin |
|---|---|---|
| FATE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 14/07/2023 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/04/2019 |
Formación de Yu Waye Chu.
| Princeton University | Undergraduate Degree |
| University of Rochester School of Medicine & Dentistry | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| FATE THERAPEUTICS, INC. | Health Technology |
| CYTOMX THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Yu Waye Chu
